Related Experiment Video

Updated: Jul 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy

Camillo Autore1, Giovanni Quarta, Paolo Spirito

  • 1Divisione di Cardiologia, Ente Ospedaliero Ospedali Galliera, Via Volta 8, Genoa 16128, Italy.

Current Treatment Options in Cardiovascular Medicine
|January 29, 2008
PubMed

Insights

Sudden cardiac death in hypertrophic cardiomyopathy (HCM) is a risk for young patients. Implantable cardioverter-defibrillators (ICDs) help prevent sudden death, but precise selection for primary prevention requires careful risk stratification.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Background:

  • Sudden cardiac death (SCD) is a severe complication of hypertrophic cardiomyopathy (HCM), often affecting young, asymptomatic individuals.
  • Implantable cardioverter-defibrillators (ICDs) are effective in preventing SCD in HCM patients.
  • Accurate risk stratification is crucial for managing HCM and guiding prophylactic ICD implantation.

Purpose of the Study:

  • To review the current understanding of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy.
  • To discuss the role of implantable cardioverter-defibrillators in both secondary and primary prevention of sudden death in HCM.
  • To highlight key risk markers used in assessing SCD risk in HCM patients.

Main Methods:

  • Review of existing literature on hypertrophic cardiomyopathy, sudden cardiac death, and implantable cardioverter-defibrillator therapy.
  • Analysis of established risk factors and emerging markers for sudden cardiac death in HCM.
  • Discussion of clinical guidelines and evidence supporting ICD implantation for HCM patients.

Main Results:

  • ICDs are definitively indicated for secondary prevention in HCM patients who have experienced cardiac arrest or sustained ventricular tachycardia.
  • Several risk markers are utilized for primary prophylactic ICD consideration, including family history, extreme left ventricular hypertrophy, nonsustained ventricular tachycardia, syncope, and exercise-induced hypotension.
  • The presence of multiple risk factors significantly increases SCD risk, while certain individual factors may also warrant prophylactic ICD implantation.

Conclusions:

  • Risk stratification is essential for identifying HCM patients at high risk of sudden cardiac death.
  • While ICDs are crucial for secondary prevention, precise criteria for primary prophylactic implantation are still evolving.
  • A comprehensive assessment of multiple risk factors is necessary to guide decisions regarding ICD implantation in hypertrophic cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...